Reuters logo
BRIEF-FDA says fagron sterile services issues voluntary nationwide recall of succinylcholine chloride
June 23, 2017 / 8:30 PM / 5 months ago

BRIEF-FDA says fagron sterile services issues voluntary nationwide recall of succinylcholine chloride

June 23 (Reuters) - Pfizer Inc:

* FDA says fagron sterile services issues voluntary nationwide recall of succinylcholine chloride due to potential for lack of sterility assurance

* FDA - recall of product manufactured by Hospira Inc is due to microbial growth detected during routine simulation of Hospira’s manufacturing process

* FDA - to date, there have been no reports of adverse events related to the succinylcholine chloride 20mg/ml 5ml syringe product Source text: (bit.ly/2rLhzXo) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below